Hepatitis C transmission model
We adopted the following system of ordinary differential equations (ODE) to model transmission of hepatitis C virus among HIV-infected men who have sex with men who do not inject drugs (see Figure 1 and heading HCV transmission model in the Subjects and Methods section). 
introduced to reflect that the population in the high-risk group is a constant proportion of those who would be classified to be at risk of unsafe sex. We assumed that the rate of potentially infectious contacts depends on the density of individuals with high-risk behaviour in a wider population. In this population, individuals in the group without high-risk behaviour are weighted by the parameter θ≤1, which we term assortativity coefficient. Model fitting procedures led to determine the best value for this parameter to be 1.
Definitions for the variables and parameters included in this model as well as a detailed description of the underlying transmission dynamics can be found in the methods section of the paper. All parameter values are shown in Table 2 .
Rate of entrance of new HCV-uninfected MSM:
Rates were obtained applying Bayesian
Poisson regression models using the R package INLA (1, 2). The INLA method uses the Laplace approximation to perform approximate Bayesian inference. Figure S2B substantially increased between those periods in the SHCS. We used a logistic function to model this transition. The maximum value of this function was the treatment rate measured for the later period (22% per year) and the minimum value was that measured for the earlier period (2% per year). We assumed that the sigmoid's midpoint was reached in 2006 and that the steepness of the curve was 1. The resulting functional form for the treatment rate was:
0.02.
Maximum likelihood Estimation to fit the transmission model: using HCV-incidence data from the SHCS
We used Maximum Likelihood Estimation (MLE) to fit the infection rate β. We calculated the likelihood of patient-level incidence data given our transmission model. For this purpose, we split the data and the simulation period (2000-2013) into monthly steps. For every time step we compared the incidence observed in the data with that produced using the model.
Individuals who seroconvert contribute to the total likelihood L with the probability of becoming infected at their individual time of infection; and individuals who never seroconvert contribute to L with the (cumulative) probability of being uninfected at the end of their individual exposure periods.
L is then given by: ln By means of this relationship we minimised the negative log-likelihood (NLL) of observed patient-level incidence data from the SHCS data given the transmission model. The final value for β is reported in Table 2 . We used a likelihood curve to estimate confidence intervals for this parameter. Figure S3 shows the likelihood curve and the corresponding confidence interval. We performed the optimizations with the R package optim (3) and solved the systems of differential equations with the R package deSolve (4, 5) .
Increasing high-risk/unsafe sex ratios led to lower estimates of the infection rate. Higher ratios also resulted in slightly improved model fits, but the maximum difference in negative log-likelihood did no exceed 0.5 (results not shown).
Uncertainty of Model Predictions
In order to assess how the uncertainty of the model parameters estimated by MLE affect the model solutions and predictions (of future HCV incidence), we used Latin Hypercube Sampling (LHS). Specifically, we sampled the infection rate β from a normal distribution that corresponds with its likelihood curve ( Figure S3 ). We sampled the exit rate μ and the external force of infection λ from lognormal distributions depicted by the mean and the standard error estimated from the SHCS data (Table 2) . We generated samples of parameters' combinations for running the simulation model using the R package clhs (6) and obtained incidence predictions for each of these combinations to determine 95% confidence intervals. Table S1 . Percentage of incident infections that are reinfections. Table S2 . Changes in high-risk behaviour. Table S3 . Sensitivity analysis on the external force of high-risk related HCV-infections (imported infections). 
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